Innovative pharmaceutical concept stocks hit bottom and rebounded, with Zhao Yan's new drug hitting the daily limit.

Innovative drug concept stocks hit bottom and rebound, Zhaoyan New Drug touched the daily limit, Yuandong Biological increased by over 10%, Guangsheng Hall, Anglikang, and Selle Medical were among the top gainers.